Zoetis Inc.

NYSE:ZTS

Drug Manufacturers - General

Healthcare
$85.55 +1.51%

+$1.17 today

Market cap
$34.76B
Beta
0.74
P/E (TTM)
12.5
EPS (TTM)
$6.26
Dividend yield
2.63%
52W Low $72.38High $161.77

Volume 4.66M

Average 6.20M

ZTS Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Zoetis Inc.NYSE: ZTS

Short-term Investments · Q2 FY2026 · quarter ended Jun 2026

Short-term investments remains negative

Q2 FY2026 short-term investments was $200M, compared with $0 a year earlier.

Context

  • Short-term investments amounted to 1.3% of total assets at the end of Q2 FY2026, up 1.3 pp from a year earlier.
  • Short-term investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$200M— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoJun 2025
$0— since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Short-term Investments vs competitors

How ZTS compares with its peers on the latest reported figures

  • ZTS's Jun 2026 short-term investments of $200M is the 2nd highest of the 6 companies compared; the peer median is $0.
  • Short-term investments amounts to 1.3% of total assets for ZTS, versus a peer median of 0.0%.
ZTS Competitors Peer median
Short-term Investments for ZTS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRKMerck & Co., Inc.Jun 2026$292M -52.5%—0.2%
ZTSZoetis Inc.Jun 2026$200M ——1.3%
PAHCPhibro Animal Health CorporationMar 2026$22.52M +125.2%-19.1%1.6%
IDXXIDEXX Laboratories, Inc.Sep 2026$0 ——0.0%
ELANElanco Animal Health IncorporatedSep 2026$0 ——0.0%
NEOGNeogen CorporationAug 2026$0 ——0.0%
Peer median (excluding ZTS) $0+36.3%-19.1%0.0%

Competitors are the stored peer set for ZTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents3.48B3.58B2.04B1.99B2.31B
Short-term Investments00000
Net Receivables1.13B1.22B1.3B1.32B1.59B
Inventory1.92B2.35B2.56B2.31B2.43B
Other Current Assets392M369M436M379M436M
Total Current Assets6.93B7.51B6.34B5.99B6.77B
Property, Plant & Equipment (Net)2.6B2.97B3.43B3.61B3.97B
Goodwill2.68B2.75B2.76B2.72B2.77B
Intangible Assets1.47B1.38B1.34B1.13B998M
Long-term Investments00030M0
Tax Assets100M173M206M540M637M
Other Non-current Assets111M147M206M220M328M
Total Non-current Assets6.97B7.42B7.94B8.25B8.7B
Total Assets13.9B14.93B14.29B14.24B15.47B
Account Payables436M405M411M433M487M
Short-term Debt01.35B3M1.35B53M
Tax Payables38M157M110M93M147M
Deferred Revenue000011M
Other Current Liabilities459M397M484M566M895M
Total Current Liabilities1.8B3.17B1.89B3.41B2.24B
Long-term Debt6.59B6.55B6.56B5.22B9.24B
Deferred Tax Liabilities320M142M146M167M139M
Deferred Revenue (Non-current)000017M
Other Non-current Liabilities496M475M508M494M305M
Total Non-current Liabilities7.56B7.36B7.41B6.06B9.9B
Total Liabilities9.36B10.52B9.3B9.47B12.14B
Common Stock5M5M5M5M5M
Retained Earnings7.19B8.67B10.3B11.97B13.74B
Accumulated OCI(764M)(817M)(839M)(940M)(834M)
Other Stockholders Equity00000
Minority Interest1M(2M)(6M)00
Total Equity4.54B4.4B4.99B4.77B3.33B
Total Debt6.74B8.09B6.76B6.74B9.49B
Net Debt3.26B4.51B4.72B4.76B7.18B

Zoetis Inc.

NYSE:ZTS

Intrinsic Alpha fair value

Locked

Current Price

$85.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.